Checklist: Hope For A Distressing Condition
UPLIZNA has proven effective at treating a broad-spectrum autoimmune disorder.
Posted on Nov 15, 2022 | 02:35pm
Brought to you by Watch
For those afflicted with the unpredictable autoimmune disease known as neuromyelitis optica spectrum disorder (NMOSD), there's possible help to be found in Horizon Therapeutics prescription medication UPLIZNA.
Caused by inflammation of the optic nerve, brain stem, and spinal cord—which make up the central nervous system—NMOSD can give rise to an array of symptoms from vision impairment, pain, spasm, sensory disturbance, motor disability, and blindness, to narcolepsy, hiccups, nausea, vomiting, respiratory problems, and loss of bowel and bladder control. Left untreated, ongoing inflammation can lead to severe attacks resulting in accumulating damage and permanent disability.
Believed to work by lowering levels of the body's B cells—UPLIZNA may inhibit the overactive immune response found in people with the disease. In an international randomized, double-blind, placebo-controlled study of 213 anti-AQP4 antibody positive patients, UPLIZNA was proven to significantly reduce those severe, permanent damage-causing attacks.
Talk to your doctor to see if UPLIZNA is right for you. Read about product information, prescribing information, medication guide, and possible side effects at uplizna.com.
Photo Credit: monkeybusinessimages/Getty Images Plus
For those afflicted with the unpredictable autoimmune disease known as neuromyelitis optica spectrum disorder (NMOSD), there's possible help to be found in Horizon Therapeutics prescription medication UPLIZNA.
Caused by inflammation of the optic nerve, brain stem, and spinal cord—which make up the central nervous system—NMOSD can give rise to an array of symptoms from vision impairment, pain, spasm, sensory disturbance, motor disability, and blindness, to narcolepsy, hiccups, nausea, vomiting, respiratory problems, and loss of bowel and bladder control. Left untreated, ongoing inflammation can lead to severe attacks resulting in accumulating damage and permanent disability.
Believed to work by lowering levels of the body's B cells—UPLIZNA may inhibit the overactive immune response found in people with the disease. In an international randomized, double-blind, placebo-controlled study of 213 anti-AQP4 antibody positive patients, UPLIZNA was proven to significantly reduce those severe, permanent damage-causing attacks.
Talk to your doctor to see if UPLIZNA is right for you. Read about product information, prescribing information, medication guide, and possible side effects at uplizna.com.
Photo Credit: monkeybusinessimages/Getty Images Plus